Business

New Research from Humana Finds Value-Based Care Delivers Higher Quality of Care for Heart Failure Patients

LOUISVILLE, Ky., August 21, 2025--Value-based care delivers a higher quality of care and better medication prescription adherence to evidence-based medicine for Medicare Advantage patients diagnosed with heart failure, according to findings released today by leading health and well-being company Humana Inc. (NYSE: HUM) in its latest Value-Based Care Issue Brief.

articleHumana Inc.August 21, 20253/company/humana-inc/news/new-research-from-humana-finds-value-based-care-delivers-higher-quality-of-care-for-heart-failure-patients
New Research from Humana Finds Value-Based Care Delivers Higher Quality of Care for Heart Failure Patients

About this update from Humana Inc.

[{"type":"image","alt":"New data from Humana Healthcare Research finds value-based care is a differentiator for patients with heart failure. Patients treated by value-based care clinicians were nearly 28% more likely to receive full quadruple therapy, guideline-directed medical therapy.","displaySize":"","headline":null,"caption":"New data from Humana Healthcare Research finds value-based care is a differentiator for patients with heart failure. Patients treated by value-based care clinicians were nearly 28% more likely to receive full quadruple therapy, guideline-directed medical therapy.","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":320,"url":"https://media.zenfs.com/en/business-wire.com/c30927820f5be1cadcd3fb32f9a43758"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/44g8nrJSue0myf3H4qCdTA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTY0MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/c30927820f5be1cadcd3fb32f9a43758","width":480,"height":320}},"lazy":false},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/330085fb17eadb73c8d681dc78029a8f"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Rc5ENAv3V2RmN443jsDnSA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/330085fb17eadb73c8d681dc78029a8f","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/ULpPWnqW4b6QYksTf9Rokg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/330085fb17eadb73c8d681dc78029a8f","width":1024,"height":512}}},{"type":"text","content":"LOUISVILLE, Ky., August 21, 2025--(BUSINESS WIRE)--Value-based care delivers a higher quality of care and better medication prescription adherence to evidence-based medicine for Medicare Advantage patients diagnosed with heart failure, according to findings released today by leading health and well-being company Humana Inc. (NYSE: HUM) in its latest Value-Based Care Issue Brief.","length":381,"tagName":"p"},{"type":"text","content":"Heart failure continues to affect a growing number of Americans, with 11.4 million expected to be diagnosed by 2050. Patients with heart failure experience a higher likel...

More updates from Humana Inc.

Humanaheart failureprimary care physicianvalue-basedquality of caremedical therapy